Influenza Vaccination Strategy for Patients With Hematologic Malignancy
Influenza Vaccination Strategy for Patients With Hematologic Malignancy
Recruiting · NCT07485855 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Influenza Vaccination Strategy for Patients With Hematologic Malignancy | Hemic and Lymphatic Diseases, Infections, Neoplasms by Site, RNA Virus Infections, hematologic disorder, hematopoietic and lymphoid system neoplasm, influenza, neoplasm, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 3 | 2026-09-01 | NCT07485855 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asan Medical Center | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 131 |